ASIC4 Antibodies

Santa Cruz Biotechnology features a diverse variety of ASIC4 monoclonal antibodies for research focused on understanding Acid-Sensing Ion Channel 4 (ASIC4). ASIC4 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ASIC4 is a member of the ASIC family, which plays a crucial role in mediating neuronal excitability and synaptic transmission. ASIC4 is involved in the detection of extracellular pH changes, making it significant in pain perception and neuroprotection. Research on ASIC4 can provide insights into various physiological and pathological processes, including neurodegenerative diseases and pain disorders. ASIC4 monoclonal antibodies enable precise detection and characterization of ASIC4 expression patterns across different tissues and experimental conditions. Studying ASIC4 distribution and activity patterns helps advance understanding of neural signaling mechanisms and potential therapeutic targets. ASIC4 research supported by Santa Cruz Biotechnology monoclonal antibodies contributes to advancing neuroscience and developing new therapeutic strategies for neurological conditions.